Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Cash Flow Reinvestment Rate
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting CN¥24.30 Million (capex CN¥24.30 Million ) from operating cash flow of CN¥61.35 Million. Explore Chengdu Easton Biopharmaceuticals Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Also explore total assets of Chengdu Easton Biopharmaceuticals Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Chengdu Easton Biopharmaceuticals Co Ltd. For live market cap and broader valuation context, see market cap of Chengdu Easton Biopharmaceuticals Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥105.96 Million | CN¥264.94 Million | CN¥86.28 Million | ▼ -11.5% |
| 2024 | 0.45x | CN¥118.92 Million | CN¥263.24 Million | CN¥117.42 Million | ▼ -78.8% |
| 2023 | 2.13x | CN¥585.44 Million | CN¥275.25 Million | CN¥175.26 Million | ▼ -56.6% |
| 2022 | 4.90x | CN¥745.03 Million | CN¥151.94 Million | CN¥339.33 Million | ▲ +97.3% |
| 2021 | 2.49x | CN¥366.88 Million | CN¥147.60 Million | CN¥256.29 Million | ▼ -59.3% |
| 2020 | 6.10x | CN¥955.44 Million | CN¥156.52 Million | CN¥198.81 Million | ▲ +372.0% |
| 2019 | 1.29x | CN¥183.40 Million | CN¥141.83 Million | CN¥95.41 Million | ▲ +181.4% |
| 2018 | 0.46x | CN¥76.63 Million | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥23.02 Million | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥17.83 Million | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥35.43 Million | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥22.04 Million | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥76.11 Million | CN¥28.12 Million | CN¥76.11 Million | — |